Sender CO & Partners, Inc. Immutep LTD Transaction History
Sender CO & Partners, Inc.
- $182 Million
- Q2 2025
A detailed history of Sender CO & Partners, Inc. transactions in Immutep LTD stock. As of the latest transaction made, Sender CO & Partners, Inc. holds 122,754 shares of IMMP stock, worth $208,681. This represents 0.11% of its overall portfolio holdings.
Number of Shares
122,754Holding current value
$208,681% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding IMMP
# of Institutions
29Shares Held
1.88MCall Options Held
19.3KPut Options Held
27.3K-
Black Rock Inc. New York, NY839KShares$1.43 Million0.0% of portfolio
-
Meridian Wealth Management, LLC373KShares$633,5900.03% of portfolio
-
Morgan Stanley New York, NY119KShares$203,0920.0% of portfolio
-
Ubs Group Ag64.8KShares$110,2310.0% of portfolio
-
Steward Partners Investment Advisory, LLC61KShares$103,7000.0% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $147M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...